At least 1 million children in Ghana, Kenya, and Malawi have received one or more doses of the world’s first malaria vaccine.
Gavi, the Vaccine Alliance, contributed more than $155 million to support the introduction, procurement, and distribution of the malaria vaccine in Gavi-eligible countries in Sub-Saharan Africa.
According to the World Health Organization (WHO), the RTS, S/AS01 (RTS, S) vaccine is safe to administer and significantly reduces lethal severe malaria, according to the malaria vaccine pilots, which were first released by the Malawian government in April 2019.
WHO said that if the vaccine will be widely used, it will save the lives of an extra 40,000 to 80,000 African children per year.
According to the 2021 World Malaria Report, global progress in lowering malaria incidence and fatalities has slowed in recent years, particularly in countries hardest afflicted by the disease.
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General said “This vaccine is not just a scientific breakthrough, it’s life-changing for families across Africa. It demonstrates the power of science and innovation for health. Even so, there is an urgent need to develop more and better tools to save lives and drive progress towards a malaria-free world.”
© Fourth Estate
® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.